![Revance Therapeutics, Inc. [RVNC] posts $356.42M loss as revenue rises 70.40% to $132.56M](/_next/image?url=http%3A%2F%2F10kinfo-appdata.s3.amazonaws.com%2Fedgar0105%2FCompanyLogos%2FUS%2FRVNC.png&w=3840&q=75)
Revance Therapeutics, Inc. [RVNC] posts $356.42M loss as revenue rises 70.40% to $132.56M
By USInMinutes
Published - Mar 04, 2023, 03:59 AM ET
Last Updated - Mar 06, 2023, 12:28 PM EST
| Net Sales: | $132.56M |
Revance Therapeutics, Inc. [RVNC] posted a loss of $356.42M, marking a fall of 26.70% for this year.
Revenue rose to $132.56M this year compared to $77.80M in the previous year.
According to the latest annual report the company has filed with the SEC, current earnings were $-356.42M, down 26.70% from $-281.31M.
The company’s net sales for the period were $132.56M, up 70.40%. Net sales in the previous year were $77.80M.
